FGF21 and coronary artery disorder: After effect size synthesis, higher FGF21 levels were independently and significantly associated with the long-term risk of MACE among patients with CAD (multivariate HR: 1.77, 95% CI: 1.40–2.23, P < 0.05, I2 = 0%, fixed-effect model; Figure 2A).